Skip to main content
Log in

ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer Oxf Engl. 2013;49(15):3140–8.

    Article  Google Scholar 

  2. Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013;20(4):1093–100.

    Article  PubMed  Google Scholar 

  3. Naffouje SA, Tulla KA, Salti GI. The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking. Med Oncol Northwood Lond Engl. 2018;35(5):69.

    Article  Google Scholar 

  4. Kepenekian V, Elias D, Passot G, Mery E, Goere D, Delroeux D, et al. Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE database: multi-institutional retrospective study. Eur J Cancer Oxf Engl. 1990;2016(65):69–79.

    Google Scholar 

  5. Chatterjee A, Kusamura S, Baratti D, Guaglio M, Battaglia L, Deraco M. Impact of perioperative systemic chemotherapy on survival in patients with diffuse malignant peritoneal mesothelioma treated with CRS-HIPEC. Ann Surg Oncol. 2024;31(1):556–66. https://doi.org/10.1245/s10434-023-13640-y.

    Article  PubMed  Google Scholar 

  6. Kusamura S, Kepenekian V, Villeneuve L, Lurvink RJ, Govaerts K, De Hingh IHJT, et al. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment, and follow-up. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2021;47(1):36–59.

    CAS  Google Scholar 

Download references

Acknowledgment

This study was partially supported by Foundation for Cancer Research in Italy (AIRC).

Funding

Partially supported by Foundation for Cancer Research in Italy (AIRC).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcello Deraco MD.

Ethics declarations

Disclosures

None to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chatterjee, A., Kusamura, S., Baratti, D. et al. ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC. Ann Surg Oncol 31, 2511–2512 (2024). https://doi.org/10.1245/s10434-023-13768-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13768-x

Navigation